Cargando…

Increased Toll-Like Receptor Activity in Patients With Metabolic Syndrome

OBJECTIVE: The metabolic syndrome (MetS) is highly prevalent and confers an increased risk for diabetes and cardiovascular disease (CVD). While MetS is a proinflammatory state, there is a paucity of data on cellular inflammation in MetS. Toll-like receptors (TLRs) are classical pattern recognition r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jialal, Ishwarlal, Huet, Beverley A., Kaur, Harmeet, Chien, Alexander, Devaraj, Sridevi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308307/ https://www.ncbi.nlm.nih.gov/pubmed/22357188 http://dx.doi.org/10.2337/dc11-2375

Ejemplares similares

Increased Adipocyte Hypertrophy in Patients with Nascent Metabolic Syndrome
por: Jialal, Ishwarlal, et al.
Publicado: (2023)

Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects
por: Dasu, Mohan R., et al.
Publicado: (2010)

High Glucose Induces Toll-Like Receptor Expression in Human Monocytes: Mechanism of Activation
por: Dasu, Mohan R., et al.
Publicado: (2008)

Dysfunctional Endothelial Progenitor Cells in Metabolic Syndrome
por: Devaraj, Sridevi, et al.
Publicado: (2012)

Role of C-Reactive Protein in Contributing to Increased Cardiovascular Risk in Metabolic Syndrome
por: Devaraj, Sridevi, et al.
Publicado: (2010)

Correlates of Insulin Resistance in Nascent Metabolic Syndrome
por: Adams-Huet, Beverley, et al.
Publicado: (2023)

Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP?
por: Devaraj, Sridevi, et al.
Publicado: (2010)

Comment on Lopes-Virella et al. Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects. Diabetes Care 2013;36:2317–2323
por: Jialal, Ishwarlal, et al.
Publicado: (2014)

AHA/ACC/Multisociety Cholesterol Guidelines: highlights
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy
por: Rajamani, Uthra, et al.
Publicado: (2014)

Erratum to “Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy”
por: Rajamani, Uthra, et al.
Publicado: (2016)

Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes
por: Devaraj, S., et al.
Publicado: (2009)

SAT-656 Both Neutrophil and Monocyte Ratios to High Density Lipoprotein Cholesterol Are Superior Biomarkers of Metabolic Syndrome
por: Ramakrishnan, Neeraj, et al.
Publicado: (2020)

Adipose Tissue Dysfunction in Nascent Metabolic Syndrome
por: Bremer, Andrew A., et al.
Publicado: (2013)

Gut Microbiome and Inflammation: A Study of Diabetic Inflammasome-Knockout Mice
por: Pahwa, Roma, et al.
Publicado: (2017)

Exploratory metabolomics of metabolic syndrome: A status report
por: Lent-Schochet, Daniella, et al.
Publicado: (2019)

Management of Hypertriglyceridemia in the Diabetic Patient
por: Jialal, Ishwarlal, et al.
Publicado: (2010)

Fetuin-A is also an adipokine
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Management of diabetic dyslipidemia: An update
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?
por: Jialal, Ishwarlal, et al.
Publicado: (2021)

Bempedoic Acid, an Inhibitor of Cholesterol Biosynthesis, Reduces Cardiovascular Events
por: Jialal, Ishwarlal, et al.
Publicado: (2023)

Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?
por: Cole, Justine, et al.
Publicado: (2023)

Current and Emerging Evidence for Toll-Like Receptor Activation in Sjögren's Syndrome
por: Kiripolsky, Jeremy, et al.
Publicado: (2018)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Ulvan Activates Chicken Heterophils and Monocytes Through Toll-Like Receptor 2 and Toll-Like Receptor 4
por: Guriec, Nathalie, et al.
Publicado: (2018)

Activation of Toll-like receptors by Burkholderia pseudomallei
por: West, T Eoin, et al.
Publicado: (2008)

The phosphoproteome of toll-like receptor-activated macrophages
por: Weintz, Gabriele, et al.
Publicado: (2010)

The Toll‐like receptor 7 agonist imiquimod increases ethanol self‐administration and induces expression of Toll‐like receptor related genes
por: Lovelock, Dennis F., et al.
Publicado: (2022)

RNA Modifications Modulate Activation of Innate Toll-Like Receptors
por: Freund, Isabel, et al.
Publicado: (2019)

Regulation of Fasting Fuel Metabolism by Toll-Like Receptor 4
por: Pang, Shanshan, et al.
Publicado: (2010)

Role of Toll-Like Receptor 4 on Osteoblast Metabolism and Function
por: Alonso-Pérez, Ana, et al.
Publicado: (2018)

Toll-Like Receptor-4 Disruption Suppresses Adipose Tissue Remodeling and Increases Survival in Cancer Cachexia Syndrome
por: Henriques, Felipe, et al.
Publicado: (2018)

Placental Toll-Like Receptor 3 and Toll-Like Receptor 7/8 Activation Contributes to Preeclampsia in Humans and Mice
por: Chatterjee, Piyali, et al.
Publicado: (2012)

Increased Toll-Like Receptors Activity and TLR Ligands in Patients with Autoimmune Thyroid Diseases
por: Peng, Shiqiao, et al.
Publicado: (2016)

Expression and activation of toll-like receptor 3 and toll-like receptor 4 on human corneal epithelial and conjunctival fibroblasts
por: Erdinest, Nir, et al.
Publicado: (2014)

Toll-Like Receptors in Atherosclerosis
por: Falck-Hansen, Mika, et al.
Publicado: (2013)

Toll-Like Receptors in Angiogenesis
por: Grote, Karsten, et al.
Publicado: (2011)

Toll-like Receptors and Thrombopoiesis
por: Tang, Xiaoqin, et al.
Publicado: (2023)

Toll-like receptor-4 is upregulated in plaque debris of patients with acute coronary syndrome more than Toll-like receptor-2
por: Satoh, Shinji, et al.
Publicado: (2014)

Altered Toll-Like Receptor Signalling in Children with Down Syndrome
por: Huggard, Dean, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4gcn0g0kb8h61h015di5jv8h9d